Machine learning application for prediction of locoregional recurrences in early oral tongue cancer: a Web-based prognostic tool.


Journal

Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 02 04 2019
accepted: 31 07 2019
revised: 26 07 2019
pubmed: 20 8 2019
medline: 13 11 2019
entrez: 19 8 2019
Statut: ppublish

Résumé

Estimation of risk of recurrence in early-stage oral tongue squamous cell carcinoma (OTSCC) remains a challenge in the field of head and neck oncology. We examined the use of artificial neural networks (ANNs) to predict recurrences in early-stage OTSCC. A Web-based tool available for public use was also developed. A feedforward neural network was trained for prediction of locoregional recurrences in early OTSCC. The trained network was used to evaluate several prognostic parameters (age, gender, T stage, WHO histologic grade, depth of invasion, tumor budding, worst pattern of invasion, perineural invasion, and lymphocytic host response). Our neural network model identified tumor budding and depth of invasion as the most important prognosticators to predict locoregional recurrence. The accuracy of the neural network was 92.7%, which was higher than that of the logistic regression model (86.5%). Our online tool provided 88.2% accuracy, 71.2% sensitivity, and 98.9% specificity. In conclusion, ANN seems to offer a unique decision-making support predicting recurrences and thus adding value for the management of early OTSCC. To the best of our knowledge, this is the first study that applied ANN for prediction of recurrence in early OTSCC and provided a Web-based tool.

Identifiants

pubmed: 31422502
doi: 10.1007/s00428-019-02642-5
pii: 10.1007/s00428-019-02642-5
pmc: PMC6828835
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

489-497

Subventions

Organisme : CSRD VA
ID : 1
Pays : United States
Organisme : Rauha Ahokkaan Säätiö (FI)
ID : 2
Organisme : Turun Yliopistollinen Keskussairaala
ID : 3
Organisme : Helsinki University Hospital Research Fund
ID : 4
Organisme : Finnish Cancer Society
ID : 5
Organisme : Finska Läkaresällskapet
ID : 6
Organisme : Maritza and Reino Salonen Foundation
ID : 7
Organisme : UOPECCAN Center of Study and Research
ID : 8

Références

Surg Oncol. 2018 Jun;27(2):123-128
pubmed: 29937161
J Viral Hepat. 2013 Apr;20(4):248-55
pubmed: 23490369
East Mediterr Health J. 2010 Jun;16(6):615-20
pubmed: 20799588
J Craniomaxillofac Surg. 2017 Jun;45(6):821-825
pubmed: 28359633
Am J Surg Pathol. 2017 Jul;41(7):950-960
pubmed: 28346327
Int J Oral Maxillofac Surg. 2015 Feb;44(2):143-50
pubmed: 25457829
Mod Pathol. 2018 May;31(5):772-779
pubmed: 29393297
Eur J Surg Oncol. 2013 Jun;39(6):648-54
pubmed: 23514791
Asian Pac J Cancer Prev. 2010;11(2):533-6
pubmed: 20843146
Br J Cancer. 2018 Feb 20;118(4):577-586
pubmed: 29190636
Oral Oncol. 2010 Sep;46(9):630-5
pubmed: 20637681
Oral Oncol. 2010 Sep;46(9):636-43
pubmed: 20637679
Pak J Biol Sci. 2008 Apr 15;11(8):1076-84
pubmed: 18819544
Cancer. 2008 Jan 15;112(2):345-51
pubmed: 18041071
Head Neck. 2012 Jul;34(7):994-1001
pubmed: 21953773
Iran J Public Health. 2011;40(2):80-6
pubmed: 23113076
Head Neck. 2019 Jan;41(1):177-184
pubmed: 30537401
Oral Dis. 2015 Sep;21(6):755-61
pubmed: 25825335
Curr Clin Pharmacol. 2007 Sep;2(3):217-26
pubmed: 18690868
Br J Cancer. 2017 Sep 5;117(6):856-866
pubmed: 28751758
Acad Radiol. 2002 Apr;9(4):410-9
pubmed: 11942655
Virchows Arch. 2015 Jul;467(1):39-46
pubmed: 25838076
Gastroenterology. 2002 Mar;122(3):606-13
pubmed: 11874992
J Surg Oncol. 2019 Mar;119(3):370-378
pubmed: 30548537
Asian Pac J Cancer Prev. 2014;15(14):5883-8
pubmed: 25081718
Cancer. 2012 Jan 1;118(1):101-11
pubmed: 21717431
Neural Netw. 2002 Jan;15(1):11-39
pubmed: 11958484

Auteurs

Rasheed Omobolaji Alabi (RO)

Department of Industrial Digitalization, School of Technology and Innovations, University of Vaasa, Vaasa, Finland.

Mohammed Elmusrati (M)

Department of Industrial Digitalization, School of Technology and Innovations, University of Vaasa, Vaasa, Finland.

Iris Sawazaki-Calone (I)

Oral Pathology and Oral Medicine, Dentistry School, Western Parana State University, Cascavel, PR, Brazil.

Luiz Paulo Kowalski (LP)

Department of Head and Neck Surgery and Otorhinolaryngology, A.C. Camargo Cancer Center, São Paulo, SP, Brazil.

Caj Haglund (C)

Research Programs Unit, Translational Cancer Biology, University of Helsinki, Helsinki, Finland.
Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Ricardo D Coletta (RD)

Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba, São Paulo, Brazil.

Antti A Mäkitie (AA)

Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Research Programme in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Tuula Salo (T)

Department of Pathology, University of Helsinki, Helsinki, Finland.
Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.
Cancer and Translational Medicine Research Unit, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.

Ilmo Leivo (I)

Institute of Biomedicine, Pathology, University of Turku, Turku, Finland.

Alhadi Almangush (A)

Research Programme in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. alhadi.almangush@helsinki.fi.
Department of Pathology, University of Helsinki, Helsinki, Finland. alhadi.almangush@helsinki.fi.
Institute of Biomedicine, Pathology, University of Turku, Turku, Finland. alhadi.almangush@helsinki.fi.
Faculty of Dentistry, University of Misurata, Misurata, Libya. alhadi.almangush@helsinki.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH